Single agent versus combination chemotherapy
โ Scribed by Vincent T. DeVita Jr.
- Book ID
- 115068623
- Publisher
- American Cancer Society
- Year
- 1975
- Tongue
- English
- Weight
- 607 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0007-9235
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract A randomized clinical trial designed to compare the effectiveness of cytoxan (CTX) alone versus a combination consisting of CTX, vincristine (Oncovin) and methotrexate (COM) in the treatment of Burkitt's lymphoma (BL) was carried out. Nineteen patients were selected at random to receive
## Background: This meta-analysis was conducted to compare the effects of single agent versus combination chemotherapy on response rate, toxicity, and survival of patients with advanced nonsmall cell lung carcinoma (nsclc). ## Methods: The authors reviewed randomized clinical trials published in
We have carried out a randomized phase Ill study in 105 patients with advanced nonsmall cell lung cancer, comparing a fourdrug cisplatin-mitomycin-based combination chemotherapy regimen t o sequential single-agent therapy. The combination chemotherapy regimen consisted of mitomycin C (10 mg/m2), vin